606 related articles for article (PubMed ID: 16480012)
1. Twenty-year results of the Hancock II bioprosthesis.
Borger MA; Ivanov J; Armstrong S; Christie-Hrybinsky D; Feindel CM; David TE
J Heart Valve Dis; 2006 Jan; 15(1):49-55; discussion 55-6. PubMed ID: 16480012
[TBL] [Abstract][Full Text] [Related]
2. Eighteen-year follow up after Hancock II bioprosthesis insertion.
Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
[TBL] [Abstract][Full Text] [Related]
3. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
Mykén PS
J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
[TBL] [Abstract][Full Text] [Related]
4. Twenty-year clinical experience with porcine bioprostheses.
Fann JI; Miller DC; Moore KA; Mitchell RS; Oyer PE; Stinson EB; Robbins RC; Reitz BA; Shumway NE
Ann Thorac Surg; 1996 Nov; 62(5):1301-11; discussion 1311-2. PubMed ID: 8893561
[TBL] [Abstract][Full Text] [Related]
5. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis.
Mykén P; Bech-Hanssen O; Phipps B; Caidahl K
J Heart Valve Dis; 2000 May; 9(3):415-22. PubMed ID: 10888100
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
[TBL] [Abstract][Full Text] [Related]
7. Carpentier-Edwards porcine bioprostheses: clinical performance assessed by actual analysis.
Jamieson WR; Miyagishima RT; Burr LH; Lichtenstein SV; Fradet GJ; Janusz MT
J Heart Valve Dis; 2000 Jul; 9(4):530-5. PubMed ID: 10947046
[TBL] [Abstract][Full Text] [Related]
8. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.
Jamieson WR; Fradet GJ; MacNab JS; Burr LH; Stanford EA; Janusz MT; Abel JG; Germann E; Cheung A
J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437
[TBL] [Abstract][Full Text] [Related]
9. Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement.
Lehmann S; Walther T; Leontjev S; Kempfert J; Rastan A; Garbade J; Borger MA; Falk V; Mohr FW
J Heart Valve Dis; 2007 Nov; 16(6):641-8; discussion 648. PubMed ID: 18095514
[TBL] [Abstract][Full Text] [Related]
10. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of valve-related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience.
Bortolotti U; Milano A; D'Alfonso A; Piccin C; Mecozzi G; Magagna P; Fabbri A; Mazzucco A
J Heart Valve Dis; 2001 Nov; 10(6):795-801. PubMed ID: 11767189
[TBL] [Abstract][Full Text] [Related]
12. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow up of the ATS mechanical heart valve.
Emery RW; Krogh CC; Jones DJ; Nicoloff DM; Blake DP; Arom KV
J Heart Valve Dis; 2004 Mar; 13(2):231-8. PubMed ID: 15086262
[TBL] [Abstract][Full Text] [Related]
14. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
[TBL] [Abstract][Full Text] [Related]
15. The mosaic valve clinical performance at seven years: results from a multicenter prospective clinical trial.
Fradet G; Bleese N; Busse E; Jamieson E; Raudkivi P; Goldstein J; Metras J
J Heart Valve Dis; 2004 Mar; 13(2):239-46; discussion 246-7. PubMed ID: 15086263
[TBL] [Abstract][Full Text] [Related]
16. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
Emery RW; Krogh CC; Arom KV; Emery AM; Benyo-Albrecht K; Joyce LD; Nicoloff DM
Ann Thorac Surg; 2005 Mar; 79(3):776-82; discussion 782-3. PubMed ID: 15734375
[TBL] [Abstract][Full Text] [Related]
17. Late results of heart valve replacement with the Hancock II bioprosthesis.
David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
[TBL] [Abstract][Full Text] [Related]
18. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
19. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland.
Minakata K; Wu Y; Zerr KJ; Grunkemeier GL; Handy JR; Ahmad A; Starr A; Furnary AP
J Heart Valve Dis; 2002 Nov; 11(6):844-50. PubMed ID: 12479287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
